Early detection of pharyngocutaneous fistulae after total laryngectomy by cytokine in drainage: A pilot study (DEFILAC).


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
12 2023
Historique:
revised: 15 09 2023
received: 21 07 2023
accepted: 23 09 2023
medline: 13 11 2023
pubmed: 10 10 2023
entrez: 10 10 2023
Statut: ppublish

Résumé

The determination of cytokines in the postoperative drainage (POD) fluid could be a method for early detection of the development of a pharyngocutaneous fistula (PCF). We conducted a prospective two-center study involving 28 patients. PODs were collected on Day 1 (D1) and Day 2 (D2) postoperatively for determination of a cytokine panel and cytobacteriological examination. Eleven (39%) patients presented with PCF on average 13 ± 5.5 days after surgery. Patients with PCF had higher IL-10 (121 vs. 40.3, p = 0.04, effect size (ES) = 0.98 [0.16, 1.79]) and TNFα level (21.2 vs. 2.2, p = 0.02, ES = 0.83 [0.03, 1.63]) on D2. An IL-10 threshold of 72 pg/mL on D2 was diagnostic of the occurrence of PCF with a sensibility of 70%, specificity of 88%. The determination of cytokines in POD fluid on D2 is a reliable tool for predicting the development of a PCF after total laryngectomy.

Sections du résumé

BACKGROUND
The determination of cytokines in the postoperative drainage (POD) fluid could be a method for early detection of the development of a pharyngocutaneous fistula (PCF).
MATERIALS AND METHODS
We conducted a prospective two-center study involving 28 patients. PODs were collected on Day 1 (D1) and Day 2 (D2) postoperatively for determination of a cytokine panel and cytobacteriological examination.
RESULTS
Eleven (39%) patients presented with PCF on average 13 ± 5.5 days after surgery. Patients with PCF had higher IL-10 (121 vs. 40.3, p = 0.04, effect size (ES) = 0.98 [0.16, 1.79]) and TNFα level (21.2 vs. 2.2, p = 0.02, ES = 0.83 [0.03, 1.63]) on D2. An IL-10 threshold of 72 pg/mL on D2 was diagnostic of the occurrence of PCF with a sensibility of 70%, specificity of 88%.
CONCLUSION
The determination of cytokines in POD fluid on D2 is a reliable tool for predicting the development of a PCF after total laryngectomy.

Identifiants

pubmed: 37815200
doi: 10.1002/hed.27535
doi:

Substances chimiques

Interleukin-10 130068-27-8
Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3067-3074

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Righini C, Atallah Y, Reyt E. Société Fr. D'ORL complicat séquelles trait en cancérologie ORL. 2013:79-82.
van la Parra RFD. The prognostic value of abnormal findings on radiographic swallowing studies after total laryngectomy. Cancer Imaging. 2007;7(1):119-125. doi:10.1102/1470-7330.2007.0015
Virtaniemi JA, Kumpulainen EJ, Hirvikoski PP, Johansson RT, Kosma VM. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae. Head Neck. 2001;23(1):29-33.
Davies JC, Hugh S, Rich JT, et al. Association of pharyngocutaneous fistula with cancer outcomes in patients after laryngectomy: a multicenter collaborative cohort study. JAMA Otolaryngol Head Neck Surg. 2021;147(12):1027-1034. doi:10.1001/jamaoto.2021.1545
Sayles M, Koonce SL, Harrison L, Beasley N, McRae AR, Grant DG. Pharyngo-cutaneous fistula complicating laryngectomy in the chemo-radiotherapy organ-preservation epoch. Eur Arch Otorhinolaryngol. 2014;271(6):1765-1769. doi:10.1007/s00405-013-2727-2
Hasan Z, Dwivedi RC, Gunaratne DA, Virk SA, Palme CE, Riffat F. Systematic review and meta-analysis of the complications of salvage total laryngectomy. Eur J Surg Oncol. 2017;43(1):42-51. doi:10.1016/j.ejso.2016.05.017
Cavalot AL, Gervasio CF, Nazionale G, et al. Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records. Otolaryngol Head Neck Surg. 2000;123(5):587-592. doi:10.1067/mhn.2000.110617
Boscolo-Rizzo P, De Cillis G, Marchiori C, Carpenè S, Da Mosto MC. Multivariate analysis of risk factors for pharyngocutaneous fistula after total laryngectomy. Eur Arch Otorhinolaryngol. 2008;265(8):929-936. doi:10.1007/s00405-007-0562-z
Paydarfar JA, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg. 2006;132(1):67. doi:10.1001/archotol.132.1.67
Liang JW, Li ZD, Li SC, Fang FQ, Zhao YJ, Li YG. Pharyngocutaneous fistula after total laryngectomy: a systematic review and meta-analysis of risk factors. Auris Nasus Larynx. 2015;42(5):353-359. doi:10.1016/j.anl.2015.04.002
Candau-Alvarez A, Gil-Campos M, De la Torre-Aguilar MJ, Llorente-Cantarero F, Lopez-Miranda J, Perez-Navero JL. Early modification in drainage of interleukin-1β and tumor necrosis factor-α best predicts surgical-site infection after cervical neck dissection for oral cancer. J Oral Maxillofac Surg. 2015;73(6):1189-1198. doi:10.1016/j.joms.2014.12.023
Asi-Bautista MC, Heidemann SM, Meert KL, Canady AI, Sarnaik AP. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection. Crit Care Med. 1997;25(10):1713-1716. doi:10.1097/00003246-199710000-00022
Moseley R, Stewart JE, Stephens P, Waddington RJ, Thomas DW. Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases? Br J Dermatol. 2004;150(3):401-413. doi:10.1111/j.1365-2133.2004.05845.x
Clementsen T, Krohn CD, Reikerås O. Systemic and local cytokine patterns during total hip surgery. Scand J Clin Lab Invest. 2006;66(6):535-542. doi:10.1080/00365510600889635
Saroul N, Pastourel R, Mulliez A, et al. Which assessment method of malnutrition in head and neck cancer? Otolaryngol Head Neck Surg. 2018;158(6):1065-1071. doi:10.1177/0194599818755995
Yilmaz KB, Dogan L, Nalbant H, et al. Comparing scalpel, electrocautery and ultrasonic dissector effects: the impact on wound complications and pro-inflammatory cytokine levels in wound fluid from mastectomy patients. J Breast Cancer. 2011;14(1):58-63. doi:10.4048/jbc.2011.14.1.58
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46.
Bender R, Lange S. Adjusting for multiple testing-when and how? J Clin Epidemiol. 2001;54(4):343-349. doi:10.1016/s0895-4356(00)00314-0
Wang M, Xun Y, Wang K, et al. Risk factors of pharyngocutaneous fistula after total laryngectomy: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2020;277(2):585-599. doi:10.1007/s00405-019-05718-9
Le Flem M, Santini L, Boulze C, et al. Early oral hydration protects against pharyngocutaneous fistula after total laryngectomy or total pharyngolaryngectomy. Head Neck. 2020;42(8):1902-1906. doi:10.1002/hed.26122
Benali J, Viljoen G, Ayad T, et al. Management of oral feeding following total laryngectomy around the world: YO-IFOS international study. Head Neck. 2022;44(8):1755-1764. doi:10.1002/hed.27026
Larsen LR, Schuller DE. Wound amylase levels as an early indicator of orocutaneous fistulae. Laryngoscope. 1984;94:1302-1306. doi:10.1288/00005537-198410000-00008
Morton RP, Mehanna H, Hall FT, McIvor NP. Prediction of pharyngocutaneous fistulas after laryngectomy. Otolaryngol Head Neck Surg. 2007;136:S46-S49. doi:10.1016/j.otohns.2006.11.030
Milinis K, Gaskell P, Lau A, Lancaster J, Jones T. Early versus late oral feeding following total (pharyngo)laryngectomy: systematic review and meta-analysis. Head Neck. 2021;43(4):1359-1368. doi:10.1002/hed.26616
Singh R, Karantanis W, Fadhil M, et al. Meta-analysis on the rate of pharyngocutaneous fistula in early oral feeding in laryngectomy patients. Am J Otolaryngol. 2021;42(1):102748. doi:10.1016/j.amjoto.2020.102748

Auteurs

Nicolas Saroul (N)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.
University of Clermont Auvergne, CHU-Clermont-Ferrand, INRAE, UNH, Clermont-Ferrand, France.

Margaux Loukine (M)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Marc Durand (M)

Department of Otolaryngology - Head and Neck Surgery, CH Emile Roux, Le Puy-en-Velay, France.

Bruno Pereira (B)

Department of Biostatistics, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Isabelle Rozand (I)

Department of Biochemistry, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Justine Becaud (J)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Quentin Martinez (Q)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Thierry Mom (T)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Laurent Gilain (L)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Bertrand Evrard (B)

Department of Clinical Immunology, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Mathilde Puechmaille (M)

Department of Otolaryngology - Head and Neck Surgery, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Benjamin Bonnet (B)

Department of Clinical Immunology, CHU-Clermont-Ferrand, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH